Skip to content

Kim R Tsuchimoto, Director at Monopar Therapeutics, sold MNPR on Aug 26, 2026

Data as of Oct 16

▼ SELL$77.5K700 shares at $110.65Kim R Tsuchimoto DirectorMNPR Monopar Therapeutics
Watch MNPR
Traded
Aug 26, 2026
Disclosed
Aug 27, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Kim R Tsuchimoto, Director at Monopar Therapeutics, sold MNPR on Aug 26, 2026TRADEDDISCLOSED
MNPRSimilar stocks (XLV — its sector index fund), rebased to MNPR's price on the disclosure day
MNPR since disclosure
−39.2%
after the sale
Similar stocks (XLV) since disclosure
+3.0%
XLV — its sector index fund

Change in closing price from Aug 27, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKim R Tsuchimoto DirectorMNPR Monopar Therapeutics$67.2Kdisclosed Aug 27 · filed 1 day after the trade
  2. ▼ SELLKim R Tsuchimoto DirectorMNPR Monopar Therapeutics$52.8Kdisclosed Aug 27 · filed 1 day after the trade
  3. ▼ SELLKim R Tsuchimoto DirectorMNPR Monopar Therapeutics$68Kdisclosed Aug 27 · filed 1 day after the trade
  4. ▼ SELLKim R Tsuchimoto DirectorMNPR Monopar Therapeutics$67.4Kdisclosed Aug 27 · filed 1 day after the trade
  5. ▼ SELLKim R Tsuchimoto DirectorMNPR Monopar Therapeutics$123Kdisclosed Aug 27 · filed 1 day after the trade

See every trade on MNPR →